Top

Gepubliceerd in:

01-03-2013 | Radicale Prostatectomie In Nederland

Radicale prostatectomie in Nederland

Auteurs: Drs. D.M. Somford, dr. J.P. van Basten

Gepubliceerd in: Tijdschrift voor Urologie | Uitgave 2/2013

Samenvatting

Radicale prostatectomie speelt een dominante rol binnen de behandeling van het gelokaliseerd prostaatcarcinoom. Toch moet de ideale techniek voor radicale prostatectomie, zowel op oncologisch als functioneel gebied nog vastgesteld worden, waarbij de minimaal invasieve technieken moeten worden vergeleken met de open procedure. Uiteraard spelen hier ook kostenoverwegingen een prominente rol. In die context is ook de discussie over volumenormen en trainingseisen voor een dergelijke procedure in volle gang.

In dit overzichtsartikel hebben wij gepoogd een compleet overzicht te geven van de huidige stand van zaken van de radicale prostatectomie in Nederland en daarnaast een visie op de toekomst te verwoorden.

vorige artikel Blaassparende behandeling bij spierinvasief blaascarcinoom. De behandeling van de toekomst

volgende artikel ‘Ik héb eigenlijk nooit complicaties’

Cremers RG, Karim-Kos HE, Houterman S, et al. Prostate cancer: trends in incidence, survival and mortality in the Netherlands, 1989-2006. Eur J Cancer. 2010;46(11):2077-87.PubMedCrossRef

Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2005;352(19):1977-84.PubMedCrossRef

Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012;367(3):203-13.PubMedCrossRef

Vickers A, Bennette C, Steineck G, et al. Individualized estimation of the benefit of radical prostatectomy from the scandinavian prostate cancer group randomized trial. Eur Urol. 2012 Aug;62(2):204-9.PubMedCrossRef

D’Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280(11):969-74.PubMedCrossRef

Kupelian PA, Potters L, Khuntia D, et al. Radical prostatectomy, external beam radiotherapy72 Gy, external beam radiotherapyor = 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys. 2004;58(1):25-33.PubMedCrossRef

Boorjian SA, Karnes RJ, Rangel LJ, et al. Mayo Clinic validation of the D’amico risk group classification for predicting survival following radical prostatectomy. J Urol. 2008;179(4):1354-60.PubMedCrossRef

Stephenson AJ, Kattan MW, Eastham JA, et al. Prostate cancerspecific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol. 2009;27(26):4300-5.PubMedCrossRef

Novara G, Ficarra V, Mocellin S, et al. Systematic review and metaanalysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol. 2012;62(3):382-404.PubMedCrossRef

10.

Sciarra A, Barentsz J, Bjartell A, et al. Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. Eur Urol. 2011;59(6):962-77.PubMedCrossRef

11.

Hricak H, Wang L, Wei DC, et al. The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy. Cancer. 2004;100(12):2655-63.PubMedCrossRef

12.

Menon M, Bhandari M, Gupta N, et al. Biochemical recurrence following robot-assisted radical prostatectomy: analysis of 1384 patients with a median 5-year follow-up. Eur Urol. 2010;58(6):838-46.PubMedCrossRef

13.

Sooriakumaran P, Haendler L, Nyberg T, et al. Biochemical recurrence after robot-assisted radical prostatectomy in a European single-centre cohort with a minimum follow-up time of 5 years. Eur Urol. 2012; 62(5):768-74.PubMedCrossRef

14.

Suardi N, Ficarra V, Willemsen P, et al. Long-term biochemical recurrence rates after robot-assisted radical prostatectomy: analysis of a single-center series of patients with a minimum follow-up of 5 years. Urology. 2012;79(1):133-8.PubMedCrossRef

15.

Connolly SS, Cathcart PJ, Gilmore P, et al. Robotic radical prostatectomy as the initial step in multimodal therapy for men with high-risk localised prostate cancer: initial experience of 160 men. BJU Int. 2012;109(5):752-9.PubMedCrossRef

16.

Hu JC, Gu X, Lipsitz SR, et al. Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA. 2009;302(14):1557-64.PubMedCrossRef

17.

Trinh QD, Sammon J, Sun M, et al. Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the nationwide inpatient sample. Eur Urol. 2012;61(4):679-85.PubMedCrossRef

18.

Murphy DG, Bjartell A, Ficarra V, et al. Downsides of robotassisted laparoscopic radical prostatectomy: limitations and complications. Eur Urol. 2010;57(5):735-46.PubMedCrossRef

19.

Di Pierro GB, Baumeister P, Stucki P, et al. A prospective trial comparing consecutive series of open retropubic and robot-assisted laparoscopic radical prostatectomy in a centre with a limited caseload. Eur Urol. 2011 Jan;59(1):1-6.PubMedCrossRef

20.

Sammon JD, Karakiewicz PI, Sun M, et al. Robot-assisted vs. open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach. J Urol. 2012. [Epub ahead of print]

21.

Mottrie A, Migem P van, Naeyer G de, et al. Robot-assisted laparoscopic radical prostatectomy: oncologic and functional results of 184 cases. Eur Urol. 2007;52(3):746-50.PubMedCrossRef

22.

Rocco B, Matei DV, Melegari S, et al. Robotic vs open prostatectomy in a laparoscopically naive centre: a matched-pair analysis. BJU Int. 2009;104(7):991-5.PubMedCrossRef

23.

Ficarra V, Novara G, Rosen RC, et al. Systematic review and metaanalysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol. 2012;62(3):405-17.PubMedCrossRef

24.

Ficarra V, Novara G, Ahlering TE, et al. Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol. 2012;62(3):418-30.PubMedCrossRef

25.

Chun FK, Briganti A, Antebi E, et al. Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients. BJU Int. 2006;98(6):1204-9.PubMedCrossRef

26.

Eastham JA, Kattan MW, Riedel E, et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol. 2003;170(6 Pt 1):2292-5.CrossRef

27.

Klein EA, Bianco FJ, Serio AM, et al. Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories. J Urol. 2008;179(6):2212-6.PubMedCrossRef

28.

Bianco FJ Jr, Vickers AJ, Cronin AM, et al. Variations among experienced surgeons in cancer control after open radical prostatectomy. J Urol. 2010;183(3):977-82.PubMedCrossRef

29.

Hohwü L, Borre M, Ehlers L, et al. A short-term cost-effectiveness study comparing robot-assisted laparoscopic and open retropubic radical prostatectomy. J Med Econ. 2011;14(4):403-9.PubMedCrossRef

30.

Vickers A, Bianco F, Cronin A, et al. The learning curve for surgical margins after open radical prostatectomy: implications for margin status as an oncological end point. J Urol. 2010;183(4):1360-5.PubMedCrossRef

31.

Secin FP, Savage C, Abbou C, et al. The learning curve for laparoscopic radical prostatectomy: an international multicenter study. J Urol. 2010;184(6):2291-6.PubMedCrossRef

Titel: Radicale prostatectomie in Nederland
Auteurs: Drs. D.M. Somford
dr. J.P. van Basten
Publicatiedatum: 01-03-2013
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Tijdschrift voor Urologie / Uitgave 2/2013
Print ISSN: 2211-3037
Elektronisch ISSN: 2211-4718
DOI: https://doi.org/10.1007/s13629-013-0012-1

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen

Andere artikelen Uitgave 2/2013

De vele gezichten van hedendaags kwaliteitsbeheer

Cystectomie, gouden standaard voor spierinvasief blaascarcinoom? Een persoonlijke visie

Blaassparende behandeling bij spierinvasief blaascarcinoom. De behandeling van de toekomst

Nederlandse Hypospadie Studie: opzet en eerste resultaten

Radicale cystectomie in Nederland in 2011. Resultaten uit de landelijke registratie

‘Ik héb eigenlijk nooit complicaties’